+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gadoxetic Acid Disodium Injection Market - Global Forecast 2026-2032- Product Image
Gadoxetic Acid Disodium Injection Market - Global Forecast 2026-2032- Product Image
Sale

Gadoxetic Acid Disodium Injection Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6140036
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gadoxetic Acid Disodium Injection Market is projected to reach USD 1.53 Billion in 2026. It is expected to continue growing at a CAGR of 7.78%, reaching USD 2.40 Billion by 2032.

Gadoxetic Acid Disodium Injection: Executive Overview

Gadoxetic acid disodium injection is a hepatobiliary contrast agent used with magnetic resonance imaging to support the characterization of focal liver lesions and the assessment of hepatobiliary function. Its clinical value is linked to the combination of dynamic vascular-phase information and delayed hepatobiliary-phase imaging. Adoption is shaped by liver-disease burden, access to MRI, radiology expertise, institutional protocols, product availability, and requirements for safe contrast administration.

Clinical Imaging Shifts Are Redefining Liver Lesion Workflows

Liver imaging is moving toward more standardized, multiparametric pathways that combine clinical history, laboratory findings, ultrasound, computed tomography, and MRI. Gadoxetic acid-enhanced MRI is particularly relevant when lesion characterization, detection of small lesions, or evaluation of hepatobiliary uptake can affect surgical planning, locoregional treatment, surveillance, or transplant assessment. Broader emphasis on appropriateness, renal-risk assessment, adverse-reaction preparedness, and protocol optimization is also influencing use. Variation in MRI availability and local practice standards remains an important barrier to consistent adoption.

Artificial Intelligence Is Supporting Protocol Selection and Image Interpretation

Artificial intelligence is increasingly being evaluated for liver segmentation, lesion detection, image registration, quantitative enhancement analysis, and structured reporting. These tools may help radiologists manage large imaging volumes and identify subtle findings across dynamic and hepatobiliary phases, but they do not replace clinical judgment or validated contrast-enhanced MRI protocols. Key implementation priorities include representative training data, explainable outputs, integration with imaging archives and reporting systems, human oversight, cybersecurity, and prospective validation across scanners, institutions, and patient populations.

Regional Differences Reflect MRI Access, Liver Disease, and Regulatory Practice

In North America, established MRI infrastructure and specialist radiology services support use in complex liver evaluation, while authorization, formulary, and protocol requirements can influence access. Europe places strong emphasis on clinical guidelines, pharmacovigilance, and standardized imaging pathways. Asia-Pacific combines advanced imaging capabilities in markets such as Japan, South Korea, Australia, and China with substantial variation in access across health systems. Latin America is influenced by uneven MRI distribution, referral concentration, and public-private differences. The Middle East shows expanding specialist and tertiary-care capacity, whereas Africa continues to face constraints involving equipment, trained personnel, supply continuity, and referral networks. Across all regions, safe administration and locally applicable guidance remain central.

Economic and Security Groups Shape Access Through Health-System Coordination

ASEAN countries face differing levels of MRI capacity, regulatory maturity, and cross-border referral integration. BRICS members encompass large and diverse patient populations with varied procurement systems and domestic manufacturing capabilities. The European Union benefits from coordinated regulatory and clinical-policy environments, although implementation differs among member states. G7 countries generally have mature diagnostic infrastructure but continue to address cost containment, workforce pressures, and equitable access. GCC health systems are strengthening tertiary imaging services and centralized procurement, while NATO members span highly diverse healthcare structures; interoperability, emergency preparedness, and supply resilience can influence diagnostic continuity.

Country-Level Priorities Range from Advanced Protocols to Capacity Building

Australia and Canada emphasize geographically equitable access across dispersed populations. Brazil and Mexico face regional disparities in specialist imaging and referral capacity. China and India are expanding diagnostic infrastructure while managing substantial differences between urban and rural services. France, Germany, Italy, Spain, and the United Kingdom operate within mature European systems where guideline alignment, reimbursement, workforce availability, and diagnostic pathways affect utilization. Japan and South Korea have advanced MRI expertise and established liver-imaging practice, with continued focus on workflow efficiency and aging populations. Russia’s access is shaped by regional infrastructure, procurement, and service continuity. In the United States, utilization is influenced by specialist referral, institutional protocols, payer policies, safety procedures, and the distribution of MRI resources.

Leaders Should Prioritize Evidence, Protocol Discipline, and Equitable Implementation

Industry leaders should align clinical evidence with clearly defined use cases, including lesion characterization, treatment planning, and hepatobiliary assessment. They should support radiologist education, standardized acquisition and reporting protocols, and practical safety processes covering patient selection, renal assessment where relevant, prior reactions, injection technique, and emergency readiness. Partnerships with hospitals can improve workflow integration and real-world evidence collection, while responsible AI development should include external validation and transparent human oversight. Supply planning, regulatory compliance, post-market surveillance, and access strategies tailored to lower-resource settings are also essential.

Methodology Combines Clinical Evidence, Health-System Analysis, and Geographic Triangulation

This executive summary uses the supplied market definition for gadoxetic acid disodium injection and synthesizes publicly verifiable clinical, regulatory, and health-system considerations. The approach assesses the agent’s diagnostic role, imaging workflow changes, artificial-intelligence applications, regional infrastructure, group-level policy environments, and country-specific access conditions. Findings are framed qualitatively to avoid unsupported market estimates, market sizing, shares, or forecasts. Interpretation should be refined with current product labeling, local regulatory decisions, clinical guidelines, procurement rules, and institution-level utilization data.

Sustainable Use Depends on Diagnostic Value, Safety, and System Readiness

Gadoxetic acid disodium injection remains most relevant where hepatobiliary-phase information can materially improve liver lesion assessment or management decisions. Its role will be shaped less by contrast availability alone than by MRI capacity, trained personnel, standardized protocols, evidence-based referral, safe administration, and effective integration with emerging software tools. Organizations that combine clinical appropriateness with workforce development, resilient supply practices, and equitable access will be better positioned to translate advanced liver imaging into dependable patient care.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Gadoxetic Acid Disodium Injection Market, by Indication
7.1. Introduction
7.2. Benign Lesions
7.3. Diffuse Liver Disease
7.4. Focal Liver Lesions
7.5. Metastases
8. Gadoxetic Acid Disodium Injection Market, by Dosage Form
8.1. Introduction
8.2. Prefilled Syringes
8.3. Vials
9. Gadoxetic Acid Disodium Injection Market, by Patient Age Group
9.1. Introduction
9.2. Adults
9.3. Pediatrics
10. Gadoxetic Acid Disodium Injection Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Diagnostic Imaging Centers
10.4.1. Hospital Affiliated Centers
10.4.2. Standalone Centers
10.5. Hospitals
10.5.1. Academic Hospitals
10.5.2. Community Hospitals
11. Gadoxetic Acid Disodium Injection Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
12. Gadoxetic Acid Disodium Injection Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Gadoxetic Acid Disodium Injection Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Gadoxetic Acid Disodium Injection Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Bayer AG
16.2. Jiangsu Yutian Pharmaceutical Co., Ltd.
16.3. Jodas Expoim
16.4. Maya Biotech
16.5. Sichuan Renan Pharmaceutical Co., Ltd.
16.6. Simson Pharma Limited
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Gadoxetic Acid Disodium Injection Market, Years Considered for the Study
FIGURE 2. Global Gadoxetic Acid Disodium Injection Market, Research Design
FIGURE 3. Global Gadoxetic Acid Disodium Injection Market, Research Framework
FIGURE 4. Global Gadoxetic Acid Disodium Injection Market, Data Triangulation
FIGURE 5. Global Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Gadoxetic Acid Disodium Injection Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 7. Global Gadoxetic Acid Disodium Injection Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 9. Global Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2025 vs 2032 (%)
FIGURE 11. Global Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Gadoxetic Acid Disodium Injection Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Gadoxetic Acid Disodium Injection Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Gadoxetic Acid Disodium Injection Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Gadoxetic Acid Disodium Injection Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Gadoxetic Acid Disodium Injection Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Gadoxetic Acid Disodium Injection Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Gadoxetic Acid Disodium Injection Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Gadoxetic Acid Disodium Injection Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Gadoxetic Acid Disodium Injection Market Segmentation & Coverage
TABLE 2. Global Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 3. Global Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 4. Global Benign Lesions Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Benign Lesions Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Benign Lesions Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Diffuse Liver Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Diffuse Liver Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Diffuse Liver Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Focal Liver Lesions Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Focal Liver Lesions Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Focal Liver Lesions Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Metastases Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Metastases Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Metastases Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 17. Global Prefilled Syringes Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Prefilled Syringes Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Prefilled Syringes Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 24. Global Adults Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Adults Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Adults Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Pediatrics Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Pediatrics Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Pediatrics Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 31. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Diagnostic Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Diagnostic Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Diagnostic Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Hospital Affiliated Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Hospital Affiliated Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Hospital Affiliated Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Standalone Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Standalone Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Standalone Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Academic Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Academic Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Academic Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Community Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Community Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Community Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 56. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Chain Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Chain Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Chain Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Independent Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Independent Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Independent Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Gadoxetic Acid Disodium Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Gadoxetic Acid Disodium Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 81. North America Gadoxetic Acid Disodium Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. North America Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 83. North America Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 84. North America Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 85. North America Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. North America Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 87. North America Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 88. North America Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 89. North America Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 90. Latin America Gadoxetic Acid Disodium Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Latin America Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 92. Latin America Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 93. Latin America Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 94. Latin America Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Latin America Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 96. Latin America Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 97. Latin America Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. Latin America Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 99. Europe Gadoxetic Acid Disodium Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Europe Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 101. Europe Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 102. Europe Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 103. Europe Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Europe Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 105. Europe Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 106. Europe Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 107. Europe Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 108. Middle East Gadoxetic Acid Disodium Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Middle East Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 110. Middle East Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 111. Middle East Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 112. Middle East Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Middle East Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 114. Middle East Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 115. Middle East Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. Middle East Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 117. Africa Gadoxetic Acid Disodium Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Africa Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 119. Africa Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 120. Africa Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 121. Africa Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Africa Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 123. Africa Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 124. Africa Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 125. Africa Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 126. Global Gadoxetic Acid Disodium Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. ASEAN Gadoxetic Acid Disodium Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. ASEAN Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 129. ASEAN Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 130. ASEAN Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 131. ASEAN Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. ASEAN Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 133. ASEAN Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 134. ASEAN Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 135. ASEAN Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 136. GCC Gadoxetic Acid Disodium Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. GCC Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 138. GCC Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 139. GCC Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 140. GCC Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. GCC Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 142. GCC Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 143. GCC Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 144. GCC Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 145. European Union Gadoxetic Acid Disodium Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. European Union Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 147. European Union Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 148. European Union Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 149. European Union Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. European Union Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 151. European Union Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 152. European Union Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. European Union Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 154. BRICS Gadoxetic Acid Disodium Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. BRICS Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 156. BRICS Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 157. BRICS Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 158. BRICS Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. BRICS Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 160. BRICS Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 161. BRICS Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. BRICS Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 163. G7 Gadoxetic Acid Disodium Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. G7 Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 165. G7 Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 166. G7 Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 167. G7 Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. G7 Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 169. G7 Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 170. G7 Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. G7 Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 172. NATO Gadoxetic Acid Disodium Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. NATO Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 174. NATO Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 175. NATO Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 176. NATO Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. NATO Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 178. NATO Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 179. NATO Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. NATO Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 181. Global Gadoxetic Acid Disodium Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 182. United States Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 183. United States Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 184. United States Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 185. United States Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 186. United States Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. United States Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 188. United States Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 189. United States Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. United States Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 191. Canada Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 192. Canada Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 193. Canada Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 194. Canada Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 195. Canada Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Canada Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 197. Canada Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 198. Canada Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. Canada Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 200. Mexico Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 201. Mexico Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 202. Mexico Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 203. Mexico Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 204. Mexico Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. Mexico Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 206. Mexico Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 207. Mexico Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. Mexico Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 209. Brazil Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 210. Brazil Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 211. Brazil Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 212. Brazil Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 213. Brazil Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Brazil Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 215. Brazil Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 216. Brazil Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 217. Brazil Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 218. United Kingdom Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 219. United Kingdom Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 220. United Kingdom Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 221. United Kingdom Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 222. United Kingdom Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. United Kingdom Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 224. United Kingdom Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 225. United Kingdom Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 226. United Kingdom Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 227. Germany Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 228. Germany Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 229. Germany Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 230. Germany Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 231. Germany Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. Germany Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 233. Germany Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 234. Germany Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 235. Germany Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 236. France Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 237. France Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 238. France Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 239. France Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 240. France Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. France Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 242. France Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 243. France Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. France Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 245. Russia Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 246. Russia Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 247. Russia Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 248. Russia Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 249. Russia Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Russia Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 251. Russia Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 252. Russia Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 253. Russia Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 254. Italy Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 255. Italy Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 256. Italy Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 257. Italy Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 258. Italy Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. Italy Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 260. Italy Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 261. Italy Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. Italy Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 263. Spain Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 264. Spain Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 265. Spain Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 266. Spain Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 267. Spain Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. Spain Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 269. Spain Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 270. Spain Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 271. Spain Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 272. China Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 273. China Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 274. China Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 275. China Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 276. China Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. China Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 278. China Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 279. China Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 280. China Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 281. India Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 282. India Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 283. India Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 284. India Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 285. India Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. India Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 287. India Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 288. India Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 289. India Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 290. Japan Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 291. Japan Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 292. Japan Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 293. Japan Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 294. Japan Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. Japan Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 296. Japan Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 297. Japan Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 298. Japan Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 299. Australia Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 300. Australia Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 301. Australia Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 302. Australia Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 303. Australia Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 304. Australia Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 305. Australia Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 306. Australia Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 307. Australia Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 308. South Korea Gadoxetic Acid Disodium Injection Market Size, 2017-2032 (USD Million)
TABLE 309. South Korea Gadoxetic Acid Disodium Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 310. South Korea Gadoxetic Acid Disodium Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 311. South Korea Gadoxetic Acid Disodium Injection Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 312. South Korea Gadoxetic Acid Disodium Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. South Korea Gadoxetic Acid Disodium Injection Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 314. South Korea Gadoxetic Acid Disodium Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 315. South Korea Gadoxetic Acid Disodium Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 316. South Korea Gadoxetic Acid Disodium Injection Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 317. Global Gadoxetic Acid Disodium Injection Market Share, by Key Player, 2025
TABLE 318. Global Gadoxetic Acid Disodium Injection Market, Key Experts

Companies Mentioned

  • Bayer AG
  • Jiangsu Yutian Pharmaceutical Co., Ltd.
  • Jodas Expoim
  • Maya Biotech
  • Sichuan Renan Pharmaceutical Co., Ltd.
  • Simson Pharma Limited

Related Topics

Related Reports

Arginine Hydrochloride for Injection Market - Global Forecast 2026-2032 - Product Image

Arginine Hydrochloride for Injection Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Compound Amino Acids & Dipeptides Injection Market - Global Forecast 2026-2032 - Product Image

Compound Amino Acids & Dipeptides Injection Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Lip injections - Global Strategic Business Report - Product Image

Lip injections - Global Strategic Business Report

  • Report
  • 474 Pages
  • Global
From
Joint Pain Injections - Global Strategic Business Report - Product Image

Joint Pain Injections - Global Strategic Business Report

  • Report
  • 378 Pages
  • Global
From
Knee Hyaluronic Acid Injections Market Report 2026 - Product Image

Knee Hyaluronic Acid Injections Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.